A Randomized Phase II Trial of Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer

Grant

Awarded By

Total Award Amount

  • 378358.00

    • Direct Costs

  • 254786.00

    • Sponsor Award Id

  • R21CA259808

    • Contributor

  • Andrew McDonald   Principal Investigator